CongBao Kang

31PUBLICATIONS
70CO-AUTHORS
Molecular targetsInfectious diseasesBiomolecular modelling and designBiologically active moleculesCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Mar 18, 2026
Discovery of Pan-TEAD Inhibitors That Disrupt YAP-TEAD Interaction as a Potential Therapy for Gastric Cancers and Mutant KRAS and EGFR Lung Cancers.

Ramesh Kumar, Joanne Thian, Joel D W Toh

|Jul 30, 2025
Entry Inhibitors of SARS-CoV-2 Targeting the Transmembrane Domain of the Spike Protein.

Kristin V Lyles, Shannon Stone, Priti Singh

|Feb 24, 2025
Fragment-Based Drug Design: From Then until Now, and Toward the Future.

Weijun Xu, Congbao Kang

|Jan 24, 2025
Leveraging Structural and Computational Biology for Molecular Glue Discovery.

Congbao Kang, Weijun Xu

|Dec 17, 2024
Perspectives on Applications of 19F-NMR in Fragment-Based Drug Discovery.

Qingxin Li, CongBao Kang

|Oct 24, 2023
Targeted Degradation of XIAP is Sufficient and Specific to Induce Apoptosis in MYCN-overexpressing High-risk Neuroblastoma.

Zhang'E Choo, Xiaoying Koh, Megan Rui En Wong

Pageof 6

Frequent Collaborators

7 joint publications

Weijun Xu

2 joint publications

David E Heppner

2 joint publications

Thomas H Keller

1 joint publications

Wanjin Hong